Get 20% Free Customization In This Report

Buy this report from - $3456

Seasonal Influenza Vaccine Market by Product Type [Type A (H1N1), Type A (H3N2), and Type B] by Age Group [Pediatrics, Adolescence, Adults and Elderly] - Global Opportunity Analysis and Industry Forecast, 2017-2023

Pharmaceuticals	LI_183898	Pages: NA	Jul 2018 \| 518 Views
Author's : NA	Tables: NA	Charts: NA	Formats*:

Seasonal influenza is an acute viral infection, which can easily spread from person to person. In addition, seasonal influenza occurs during winter and can affect a person of any age group. Vaccination against seasonal influenza is known as seasonal influenza vaccine. The key factor that drives the growth of this market is the increase in incidences of influenza virus globally. However, limited production capacity as well as stringent regulations by governing bodies will be a major restraint for this market. Moreover, advancements in technology can improve the pace by which these vaccines are developed, thereby creating more lucrative opportunities for key market players.

The seasonal influenza vaccine market is segmented on the basis of product type, application, and geography. Based on product type this market is segmented into type A (H1N1), type A (H3N2), and type B. Based on age group this market is segmented into pediatrics, adolescence, adults, and elderly. By geography, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as GlaxoSmithKline plc, Sinovac Biotech Ltd., Changsheng Bio-Technology Co., Ltd., Ccbio SA, Aleph Biomedical, Sanofi S.A., Jiangsu Simcere Vaxtec Bio-pharmaceutical Co., Ltd., Dalian Hissen Bio-pharm, Abbott Laboratories, and Novartis International AG have also been provided in this report.

Key Benefits

This report provides an extensive analysis of the current and emerging market trends and dynamics in the global seasonal influenza vaccine market.
In-depth analysis has been carried out in this report by constructing market estimations for key market segments between 2016 and 2023.
Geographically, the global seasonal influenza vaccine market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
This study that evaluates the competitive landscape and value chain has been taken into account to help understand the competitive environment globally.
Comprehensive analysis of factors that drive and restrict the growth of the global seasonal influenza vaccine market has been provided.
This report provides the quantitative analysis of the current market and estimations from 2016-2023, which assists in identifying prevailing market opportunities

Seasonal Influenza Vaccine Market Key Segments:

By Product Type

Type A (H1N1)
Type A (H3N2)
Type B

By Age Group

Pediatrics
Adolescence
Adults
Elderly

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- UK
- France
- Germany
- Spain
- Rest of Europe
Asia-Pacific
- China
- India
- Australia
- Japan
- Rest of Asia-Pacific
LAMEA
- Brazil
- Turkey
- Saudi Arabia
- South Africa
- Rest of LAMEA

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 SEASONAL INFLUENZA VACCINE MARKET, BY PRODUCT TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. TYPE A (H1N1)

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. TYPE A (H3N2)

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. TYPE B

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

Chapter: 5 SEASONAL INFLUENZA VACCINE MARKET, BY AGE GROUP

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. PEDIATRICS

5.2.1. Key market trends

5.3. ADOLESCENCE

5.3.1. Key market trends

5.4. ADULTS

5.4.1. Key market trends

5.5. ELDERLY

5.5.1. Key market trends

Chapter: 6 SEASONAL INFLUENZA VACCINE MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America Seasonal Influenza Vaccine Market by Product Type
6.2.5. North America Seasonal Influenza Vaccine Market by End User

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Spain market size and forecast
6.3.3.5. Rest of Europe market size and forecast

6.3.4. Europe Seasonal Influenza Vaccine Market by Product Type
6.3.5. Europe Seasonal Influenza Vaccine Market by End User

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific Seasonal Influenza Vaccine Market by Product Type
6.4.5. Asia-Pacific Seasonal Influenza Vaccine Market by End User

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast

6.5.4. LAMEA Seasonal Influenza Vaccine Market by Product Type
6.5.5. LAMEA Seasonal Influenza Vaccine Market by End User

Chapter: 7 COMPANY PROFILES

7.1. GLAXOSMITHKLINE PLC

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. SINOVAC BIOTECH LTD.

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. CHANGSHENG BIO-TECHNOLOGY CO., LTD.

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. CCBIO SA

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. ALEPH BIOMEDICAL

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. SANOFI S.A.

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. JIANGSU SIMCERE VAXTEC BIO-PHARMACEUTICAL CO., LTD.

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. DALIAN HISSEN BIO-PHARM

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. ABBOTT LABORATORIES

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. NOVARTIS INTERNATIONAL AG

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Shopping Cart is Empty..

Your Shopping Cart Is Empty

Seasonal Influenza Vaccine Market by Product Type [Type A (H1N1), Type A (H3N2), and Type B] by Age Group [Pediatrics, Adolescence, Adults and Elderly] - Global Opportunity Analysis and Industry Forecast, 2017-2023